PALI
PALISADE BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.59
−6.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 165.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.28x
- Price / sales
- 554.18x
- Price / cash flow
- -15.23x
Enterprise value
- Enterprise value
- $151.9M
- EV / sales
- 303.84x
- EV / EBITDA
- -4.57x
- EV / EBIT
- -4.30x
- Market cap
- $277.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026